CVR 38169866Private limited company (ApS)Forskning og eksperimentel udvikling indenfor bioteknologi (721100)HørsholmFounded 1 Nov 2016
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Immumap Services ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
3
CVR, 2022
Gross profit
521K
DKK, annual report 2020
-22.7% on 2019
Result
-1.3M
DKK, annual report 2020
Equity
-3.5M
DKK, annual report 2020
MOLIOR HOLDING ApSCVR 35257918, 15% to under 20% of capital and votes, until 2 Mar 2023
TM Frøsig Invest ApSCVR 38002139, 15% to under 20% of capital and votes, until 2 Mar 2023
and 6 moreHouman Pourhassanuntil 9 Mar 2022
No current owner is registered.
CVR 299161285% to under 10% of capital and votesnotified 9 Jun 20211 Nov 2016 to 2 Mar 2023
CVR 3108098320% to under 25% of capital and votesnotified 14 Aug 20201 Nov 2016 to 14 Aug 2020
CVR 3525791815% to under 20% of capital and votesnotified 9 Jun 20211 Nov 2016 to 2 Mar 2023
CVR 2944864710% to under 15% of capital and votes9 Jun 2021 to 2 Mar 2023
CVR 327728895% to under 10% of capital and votesnotified 9 Jun 202117 May 2017 to 2 Mar 2023
CVR 3800213915% to under 20% of capital and votesnotified 9 Jun 20211 Nov 2016 to 2 Mar 2023
CVR 3803487115% to under 20% of capital and votesnotified 9 Jun 20211 Nov 2016 to 2 Mar 2023
CVR 4151993215% to under 20% of capital and votesnotified 9 Jun 202114 Aug 2020 to 2 Mar 2023
CVR 4164695010% to under 15% of capital and votes9 Jun 2021 to 2 Mar 2023
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
Founded 1 Nov 2016.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Jan 2022, monthly: 3 employees, 6 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 4 | 5 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 2 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 7 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Jan 2022, published 9 Mar 2024.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2020, DKK: Gross profit 521K, Operating profit -1.1M, Result for the year -1.3M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2020, DKK: Total assets 362.6K, Equity -3.5M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Gross profit | -318 | 1,402 | 674 | 521 |
| Operating profit | -1,222 | +103 | -908 | -1,102 |
| Result for the year | -1,247 | -3 | -1,037 | -1,282 |
| Equity | -1,197 | -1,200 | -2,237 | -3,519 |
| Total assets | 256 | 1,006 | 575 | 363 |
| Employees (average) | 2 | 3 | 3 | 4 |
| Credit metrics (Dandex calculations) | ||||
| Gross profit growth (vækst i bruttofortjeneste) | Not reportednote 1 | Not reportednote 2 | -51.9% | -22.7% |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | |||
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | Not reportednote 2 | 0% | 33.3% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | |||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | |||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | |||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | |||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | |||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | |||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | |||
Not every period is a full year: 2017 covers 14 months (1 Nov 2016 to 31 Dec 2017). Changes against it compare periods of different length.
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Immumap Services ApS:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 1,000,000, cash price 80.00, implied value 5,000,000 | 80.00 | 1,000,000 | 5,000,000 | 62,500 | |
| FoundingCashPaid in 50,000 | None | 50,000 | None | 50,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
8 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Konkursbehandlingen afsluttet 02.03.2023, virksomheden opløst
Konkursdekret afsagt 09.03.2022 af Sø- og Handelsrettens Skifteretsafdeling
Bestyrelse:
Fratrådte:
Jeppe Ragnar Andersen, den 09.03.2022, Søren Elmann Ingerslev, (formand), den 09.03.2022, Jan Friis Jørgensen, den 09.03.2022.
Direktion:
Fratrådte:
Houman Pourhassan, den 09.03.2022.
Revision:
Fratrådte:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 09.03.2022.
Direktion:
Fratrådte:
Thomas Mørch Frøsig, den 31.01.2022.
Tiltrådte:
Houman Pourhassan, den 01.02.2022.
Ny adresse: Agern Alle 3, 2970 Hørsholm
Ny kommune: Rudersdal
Vedtægter ændret: 09.06.2021
Kapitalforhøjelsen er besluttet den 09.06.2021.
kr. 12.500,00, indbetalt kontant, kurs 8.000,00.
Kapitalen udgør herefter kr. 62.500,00.
Bestyrelse:
Fratrådte:
Sine Hadrup, den 09.06.2021.
Tiltrådte:
Jeppe Ragnar Andersen, den 09.06.2021, Jan Friis Jørgensen, den 09.06.2021.
Bestyrelse:
Fratrådte:
Jørgen Schøller, den 24.11.2020.
Ny adresse: Diplomvej 377, 1., 2800 Kgs. Lyngby
Ny kommune: Lyngby-Taarbæk
Stiftelsesdato: 01.11.2016.
Virkningsdato: 01.11.2016.
Seneste vedtægtsdato: 01.11.2016.
Kapital:
kr. 50.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 50.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
CVR-NR. 29916128 VIGGO HARBOE 2006 HOLDING ApS, Røndevej 25, 8400 Ebeltoft, den 01.11.2016, CVR-NR. 31080983 JS BIOFUTURE INVEST ApS, Sverigesvej 13A, 2800 Kgs.Lyngby, den 01.11.2016, CVR-NR. 35257918 MOLIOR HOLDING ApS, Henningsens Alle 23, 1., 2900 Hellerup, den 01.11.2016, CVR-NR. 38002139 TM Frøsig Invest IVS, Belsager 27, 2670 Greve, den 01.11.2016, CVR-NR. 38034871 Hadrup BioMed Holding IVS, Kirkebakken 12, 2830 Virum, den 01.11.2016.
Bestyrelse:
Søren Elmann Ingerslev (formand), den 01.11.2016, Sine Hadrup, den 01.11.2016, Jørgen Schøller, den 01.11.2016.
Direktion:
Thomas Mørch Frøsig, den 01.11.2016.
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse..
Revision:
CVR-NR. 33963556 DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, Weidekampsgade 6, 2300 København S, den 01.11.2016.
Første regnskabsår:
01.11.2016 - 31.12.2017.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er som en contract research organization (CRO) at udføre immunomonitorerings- og epitop discovery service med avancerede immunologiske målinger, samt, efter ledelsens skøn, hermed beslægtet virksomhed.
P-number 1021910615Agern Alle 3, 2970 Hørsholm